These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1118 related articles for article (PubMed ID: 8794906)
1. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Chieng B; Connor M; Christie MJ Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906 [TBL] [Abstract][Full Text] [Related]
2. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Connor M; Vaughan CW; Chieng B; Christie MJ Br J Pharmacol; 1996 Dec; 119(8):1614-8. PubMed ID: 8982509 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079 [TBL] [Abstract][Full Text] [Related]
4. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Connor M; Ingram SL; Christie MJ Br J Pharmacol; 1997 Dec; 122(8):1567-72. PubMed ID: 9422800 [TBL] [Abstract][Full Text] [Related]
5. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. Budai D; Fields HL J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431 [TBL] [Abstract][Full Text] [Related]
7. Opioid actions on neurons of rat lateral amygdala in vitro. Sugita S; North RA Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129 [TBL] [Abstract][Full Text] [Related]
8. Cyclic somatostatin analogues as potent antagonists at mu-, but not delta- and kappa-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Mulder AH; Wardeh G; Hogenboom F; Kazmierski W; Hruby VJ; Schoffelmeer AN Eur J Pharmacol; 1991 Nov; 205(1):1-6. PubMed ID: 1687463 [TBL] [Abstract][Full Text] [Related]
9. Opioid actions on rat anterior cingulate cortex neurons in vitro. Tanaka E; North RA J Neurosci; 1994 Mar; 14(3 Pt 1):1106-13. PubMed ID: 7907137 [TBL] [Abstract][Full Text] [Related]
10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related]
11. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain. Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293 [TBL] [Abstract][Full Text] [Related]
12. Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Connor M; Borgland SL; Christie MJ Br J Pharmacol; 1999 Dec; 128(7):1561-9. PubMed ID: 10602337 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine. Mundey MK; Ali A; Mason R; Wilson VG Br J Pharmacol; 2000 Nov; 131(5):893-902. PubMed ID: 11053208 [TBL] [Abstract][Full Text] [Related]
14. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors. Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of naturally occurring and synthetic opioid tetrapeptides acting on locus coeruleus neurons. Yang YR; Chiu TH; Chen CL Eur J Pharmacol; 1999 May; 372(3):229-36. PubMed ID: 10395016 [TBL] [Abstract][Full Text] [Related]
16. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action. Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089 [TBL] [Abstract][Full Text] [Related]
17. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
18. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling. Szücs M; Boda K; Gintzler AR J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951 [TBL] [Abstract][Full Text] [Related]
19. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Chieng B; Christie MJ Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601 [TBL] [Abstract][Full Text] [Related]
20. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]